Chris Yates completed his specialist training in Diabetes and Endocrinology at the Royal Melbourne Hospital and Western Health. Using continuous glucose monitoring, his PhD at the University of Melbourne investigated steroid induced diabetes in recent kidney transplant recipients. Alongside his PhD studies, Chris helped to establish the Royal Melbourne Fracture Liaison Service to improve the detection and treatment of osteoporosis. He then undertook a postdoctoral fellowship with Professor Rajesh Thakker at the University of Oxford studying the molecular biology of neuroendocrine tumours in MEN1. He is now employed as an Endocrinologist at the Royal Melbourne Hospital, where he is the Stream Leader for Pituitary Tumours and Head of Bone and Mineral Medicine. He is also Co-Director of Endocrine Research at Western Health and Co-Chair of the Australian and New Zealand Pituitary Alliance. His current research interests include: the molecular pathogenesis of pituitary adenomas, the clinical utility of peripheral quantitative CT in fracture prediction, and the use of continuous glucose monitoring to assess steroid-induced diabetes.